Back

PCSK9: Cardiovascular role beyond the liver.

25 August 2018 (09:45 - 10:07)
Organised by:
Congress Presentation Part of: New insights into lipid biology and cardiovascular disease Lipids, Metabolism ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

3 More presentations in this session

Presentation thumbnail
Novel aspects of apolipoprotein profiling for cardiovascular risk.
Professor M. Mayr (London, GB)
Slides Video
Presentation thumbnail
The platelet oxidised lipidome in cardiovascular disease.
Professor M. Gawaz (Tuebingen, DE)
Presentation thumbnail
Lipoprotein(a): From biology to the clinic.
Professor S. Tsimikas (La Jolla, US)
Slides Video

Access the full session

Session thumbnail
New insights into lipid biology and cardiovascular disease

The Event

Event poster

ESC Congress 2018

25 August 2018 09:45 CET
You may be interested in
thumbnail
Congress Presentation
The effect of proprotein convertase subtilisin/kexin type 9 inhibition on the plasma proteome: a SPIRE sub-study
28 August 2023
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials
30 August 2021
thumbnail
Congress Presentation
Effect and safety of PCSK9 inhibitor in-hospital use on blood lipid level in the ACS patients: a systematic review and meta-analysis
13 April 2024
thumbnail
Congress Presentation
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources